|1.||Moral-Sanz, Javier: 1 article (06/2015)|
|2.||González, Constancio: 1 article (06/2015)|
|3.||Agapito, Teresa: 1 article (06/2015)|
|4.||Perez-Vizcaino, Francisco: 1 article (06/2015)|
|5.||Prieto-Lloret, Jesus: 1 article (06/2015)|
|6.||Yubero, Sara: 1 article (06/2015)|
|7.||Castañeda, Javier: 1 article (06/2015)|
|8.||Ramirez, Maria: 1 article (06/2015)|
|9.||Rigual, Ricardo: 1 article (06/2015)|
|10.||Obeso, Ana: 1 article (06/2015)|
|1.||Colorectal Neoplasms (Colorectal Cancer)
08/25/1999 - "One hundred ten cases primarily diagnosed and classified on FNA material as centroblastic-centrocytic (CBCC) and centrocytic (CC) non-Hodgkin lymphomas (NHLs) (Kiel classification) were included in the study. "
10/01/1989 - "Lymphocytic (LC) and follicular centroblastic-centrocytic (fCBCC) lymphomas had a median symptom-free period of 2 years, which was four times longer than that for immunocytoma (IC) and follicular and diffuse CBCC (fdCBCC). "
12/15/1983 - "Histologic material from 44 patients with follicular center cell lymphomas with a follicular growth pattern was divided into five groups on the basis of the predominating neoplastic cell type(s), i.e., small centrocytes with occasional centroblasts (SCC), centrocytes and few (CBCC/A) or many (CBCC/B) centroblasts, small and large centrocytes (SLCC), and small and large centroblasts (SLCB). "
12/15/1983 - "On the basis of the predominating neoplastic cell type, a cytologic subdivision of the lymphomas was made, characterizing the following subgroups: SCC (small centrocytes with occasional centroblasts), CBCC/A (centrocytes with several centroblasts), and CBCC/B (centrocytes with many centroblasts), SLCC (small and large centrocytes), SLCB (small and large centroblasts). "
11/01/1983 - "All CBCC and CC lymphomas expressed monotypic Ig, but only 66 per cent of the CB lymphomas. "
|3.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/01/1992 - "CD43 expression was studied in 131 immunophenotypically defined B cell lymphomas, including lymphocytic lymphoma (Lc, n = 13), centrocytic lymphoma (Cc, n = 14), and a range of follicle centre cell lymphomas (FCC) including centroblastic/centrocytic follicular (CbCcF, n = 48), centroblastic diffuse (CbD, n = 39), centroblastic/centrocytic diffuse (CbCcD, n = 4), centroblastic follicular and diffuse (Cb FD, n = 3) and centroblastic/centrocytic follicular and diffuse (CbCc FD, n = 1). "
05/01/1998 - "Immunohistochemical analysis showed that for low-grade lymphomas, cyclin D1 was expressed by 83% of centroblastic centrocytic (CBCC) and 14% of small lymphocytic lymphomas (SLL). "
|5.||thymidine 5'-triphosphate (TTP)
|1.||Combination Drug Therapy (Combination Chemotherapy)